Skip to main content
. 2023 Jan 12;19(1):e1011063. doi: 10.1371/journal.ppat.1011063

Fig 2. Comorbidities that may synergize with COVID-19 to predispose risks to PH.

Fig 2

The possible interactions between long COVID state and preexisting comorbidities that may contribute to pulmonary vascular remodeling and the development of PH. Created with BioRender.com. COVID-19, Coronavirus Disease 2019; HIF1-α, hypoxia-inducible factor 1-alpha; PH, pulmonary hypertension; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2; TGF-β, transforming growth factor-beta.